Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia.

Autor: Ershova JV; U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA. jhe3@cdc.gov., Volchenkov GV; Vladimir Oblast TB Dispensary, Vladimir, Russia., Somova TR; Vladimir Oblast TB Dispensary, Vladimir, Russia., Kuznetsova TA; Vladimir Oblast TB Dispensary, Vladimir, Russia., Kaunetis NV; Vladimir Oblast TB Dispensary, Vladimir, Russia., Kaminski D; U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA., Demikhova OV; Central Tuberculosis Research Institute, Moscow, Russia., Chernousova LN; Central Tuberculosis Research Institute, Moscow, Russia., Vasilyeva IA; Central Tuberculosis Research Institute, Moscow, Russia., Kerr EM; Emory University, Atlanta, GA, USA., Cegielski JP; U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA., Kurbatova EV; U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.

Publikováno v: BMC infectious diseases [BMC Infect Dis] 2020 Jul 25; Vol. 20 (1), pp. 543. Date of Electronic Publication: 2020 Jul 25.

Performance of Cepheid ® Xpert MTB/RIF ® and TB-Biochip ® MDR in two regions of Russia with a high prevalence of drug-resistant tuberculosis.

Autor: Kurbatova EV; The U.S. Centers for Disease Control and Prevention, CDC, Atlanta, GA 30333, USA., Kaminski DA, Erokhin VV, Volchenkov GV, Andreevskaya SN, Chernousova LN, Demikhova OV, Ershova JV, Kaunetis NV, Kuznetsova TA, Larionova EE, Smirnova TG, Somova TR, Vasilieva IA, Vorobieva AV, Zolkina SS, Cegielski JP

Publikováno v: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology [Eur J Clin Microbiol Infect Dis] 2013 Jun; Vol. 32 (6), pp. 735-43. Date of Electronic Publication: 2012 Dec 22.

Xpert MTB/RIF Use Is Associated With Earlier Treatment Initiation and Culture Conversion Among Patients With Sputum Smear-Negative Multidrug-Resistant Tuberculosis.

Autor: Kipiani, Maia^1,2 (AUTHOR) maiagegechkori@yahoo.com, Graciaa, Daniel S³ (AUTHOR), Buziashvili, Mariana¹ (AUTHOR), Darchia, Lasha⁴ (AUTHOR), Avaliani, Zaza¹ (AUTHOR), Tabagari, Nino⁵ (AUTHOR), Mirtskhulava, Veriko⁶ (AUTHOR), Kempker, Russell R³ (AUTHOR)

Publikováno v: Open Forum Infectious Diseases. Dec2021, Vol. 8 Issue 12, p1-8. 8p.

Diagnostic biomarkers for active tuberculosis: progress and challenges.

Autor: Nogueira, Betânia M F, Krishnan, Sonya, Barreto‐Duarte, Beatriz, Araújo‐Pereira, Mariana, Queiroz, Artur T L, Ellner, Jerrold J, Salgame, Padmini, Scriba, Thomas J, Sterling, Timothy R, Gupta, Amita, Andrade, Bruno B

Publikováno v: EMBO Molecular Medicine; 12/7/2022, Vol. 14 Issue 12, p1-13, 13p

The Impact of a Line Probe Assay Based Diagnostic Algorithm on Time to Treatment Initiation and Treatment Outcomes for Multidrug Resistant TB Patients in Arkhangelsk Region, Russia.

Autor: Eliseev, Platon¹ pediatrics@yandex.ru, Balantcev, Grigory², Nikishova, Elena³, Gaida, Anastasia³, Bogdanova, Elena², Enarson, Donald⁴, Ornstein, Tara⁴, Detjen, Anne⁴, Dacombe, Russell⁵, Gospodarevskaya, Elena⁵, Phillips, Patrick P. J.⁶, Mann, Gillian⁵, Squire, Stephen Bertel⁵, Mariandyshev, Andrei¹

Publikováno v: PLoS ONE. 4/7/2016, Vol. 11 Issue 4, p1-13. 13p.